Accéder au contenu
Merck

Synthesis and structure-activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs.

Bioorganic & medicinal chemistry (2011-08-10)
Shuang-Xi Gu, Qiu-Qin He, Shi-Qiong Yang, Xiao-Dong Ma, Fen-Er Chen, Erik De Clercq, Jan Balzarini, Christophe Pannecouque
RÉSUMÉ

A series of 26 diarylpyrimidines, characterized by the hydroxymethyl linker between the left wing benzene ring and the central pyrimidine, were synthesized and evaluated for in vitro anti-HIV activity. Most of the compounds exhibited moderate to excellent activities against wild-type HIV-1. Among them, compound 10i, bearing a chlorine atom at the C-2 position of left benzene ring, was the best congener and showed potent activity against wild-type HIV-1 with an EC(50) value of 0.009 μM, along with moderate activities against the double RT mutant (K103N+Y181C) HIV-1(III(B)) and HIV-2(ROD) with an EC(50) value of 6.2 and 6.0 μM, respectively. The preliminary structure-activity relationship (SAR) of this new series of compounds was also investigated.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2′,3′-Dideoxycytidine, ≥98% (HPLC)